The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer
Open accessAbstract
Taken together, these results provide evidence to suggest that therapeutic approaches targeting USP7, in combination with immunotherapy, should be considered for lung cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
The biology and management of non-small cell lung cancer
Herbst, R. S., Morgensztern, D., & Boshoff, C. (2018) · Nature · doi:10.1038/nature25183 · Cited by 4,891
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Lung cancer: current therapies and new targeted treatments
Hirsch, F. R., Scagliotti, G. V., Mulshine, J. L., Kwon, R., Curran, W. J., Wu, Y.-L., & Paz-Ares, L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30958-8 · Cited by 3,283
Macrophage activation and polarization
Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Breaking the chains: structure and function of the deubiquitinases
Komander, D., Clague, M. J., & Urbé, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2731 · Cited by 1,969
The cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,393
Targeting tumor-associated macrophages in cancer
Pathria, P., Louis, T. L., & Varner, J. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.02.003 · Cited by 933
Breaking the chains: deubiquitylating enzyme specificity begets function
Clague, M. J., Urbé, S., & Komander, D. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0099-1 · Cited by 832
Ubiquitylation at the crossroads of development and disease
Rape, M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.83 · Cited by 614
Chauhan, D., Tian, Z., Nicholson, B., Kumar, K. G. S., Zhou, B., Carrasco, R., McDermott, J. L., Leach, C. A., Fulcinniti, M., Kodrasov, M. P., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.007 · Cited by 589
Chen, D., Xie, J., Fiskesund, R., Dong, W., Liang, X., Lv, J., Jin, X., Liu, J., Mo, S., Zhang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03225-9 · Cited by 489
Molecular basis of USP7 inhibition by selective small-molecule inhibitors.
Turnbull, A. P., Ioannidis, S., Krajewski, W. W., Pinto-Fernandez, A., Heride, C., Martin, A. C. L., Tonkin, L. M., Townsend, E. C., Buker, S. M., Lancia, D. R., et al. (2017) · Nature · doi:10.1038/nature24451 · Cited by 463
Rody, A., Holtrich, U., Pusztai, L., Liedtke, C., Gaetje, R., Ruckhaeberle, E., Solbach, C., Hanker, L., Ahr, A., Metzler, D., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2234 · Cited by 460
Deubiquitinases in cancer: new functions and therapeutic options
Fraile, J. M., Quesada, V, Rodríguez, D., Freije, J. M. P., & López-Otín, C. (2012) · Oncogene · doi:10.1038/onc.2011.443 · Cited by 453
Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages
Bohn, T., Rapp, S., Luther, N., Klein, M., Bruehl, T.-J., Kojima, N., Aranda Lopez, P., Hahlbrock, J., Muth, S., Endo, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0226-8 · Cited by 436
USP7 small-molecule inhibitors interfere with ubiquitin binding.
Kategaya, L., Di Lello, P., Rougé, L., Pastor, R., Clark, K. R., Drummond, J., Kleinheinz, T., Lin, E., Upton, J.-P., Prakash, S., et al. (2017) · Nature · doi:10.1038/nature24006 · Cited by 333
van Loosdregt, J., Fleskens, V., Fu, J., Brenkman, A. B., Bekker, C. P. J., Pals, C. E. G. M., Meerding, J., Berkers, C. R., Barbi, J., Gröne, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.018 · Cited by 317
Macrophages, Inflammation, and Lung Cancer
Conway, E. M., Pikor, L. A., Kung, S. H. Y., Hamilton, M. J., Lam, S., Lam, W. L., & Bennewith, K. L. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1545ci · Cited by 286
Schmall, A., Al-tamari, H. M., Herold, S., Kampschulte, M., Weigert, A., Wietelmann, A., Vipotnik, N., Grimminger, F., Seeger, W., Pullamsetti, S. S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1137oc · Cited by 259
Hu, M., Gu, L., Li, M., Jeffrey, P. D., Gu, W., & Shi, Y. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040027 · Cited by 251
Wan, C., Sun, Y., Tian, Y., Lu, L., Dai, X., Meng, J., Huang, J., He, Q., Wu, B., Zhang, Z., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay9789 · Cited by 251
Self-citationUSP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
Palazón‐Riquelme, P., Worboys, J. D., Green, J., Valera, A., Martín‐Sánchez, F., Pellegrini, C., Brough, D., & López‐Castejón, G. (2018) · EMBO reports · doi:10.15252/embr.201744766 · Cited by 188
Saeed, M., Gao, J. X., Shi, Y., Lammers, T., & Yu, H. (2019) · Theranostics · doi:10.7150/thno.37568 · Cited by 156
Canning, M., Boutell, C., Parkinson, J., & Everett, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402885200 · Cited by 147
USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth
An, T., Gong, Y., Li, X., Kong, L., Ma, P., Gong, L., Zhu, H., Yu, C., Liu, J., Zhou, H., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.02.011 · Cited by 142
USP7: Novel Drug Target in Cancer Therapy
Wang, Z., Kang, W.-T., You, Y., Pang, J., Ren, H., Suo, Z., Liu, H., & Zheng, Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00427 · Cited by 139
USP19 Inhibits TNF-α– and IL-1β–Triggered NF-κB Activation by Deubiquitinating TAK1
Lei, C., Wu, X., Zhong, X., Jiang, L., Zhong, B., & Shu, H. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900083 · Cited by 125
Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis
Su, D., Ma, S., Shan, L., Wang, Y., Wang, Y., Cao, C., Liu, B., Yang, C., Wang, L., Tian, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120518 · Cited by 122
USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis
Ma, A., Tang, M., Zhang, L., Wang, B., Yang, Z., Liu, Y., Xu, G., Wu, L., Jing, T., Xu, X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0590-8 · Cited by 121
Wang, Y.-C., Wu, Y.-S., Hung, C.-Y., Wang, S.-A., Young, M., Hsu, T.-I., & Hung, J.-J. (2018) · Nature Communications · doi:10.1038/s41467-018-06178-1 · Cited by 108
The role of macrophage phenotype in regulating the response to radiation therapy
Shi, X., & Shiao, S. L. (2017) · Translational research · doi:10.1016/j.trsl.2017.11.002 · Cited by 102
USP7: Target Validation and Drug Discovery for Cancer Therapy
Zhou, J., Wang, J., Chen, C., Yuan, H., Wen, X., & Sun, H. (2018) · Medicinal Chemistry · doi:10.2174/1573406413666171020115539 · Cited by 100
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
Jin, Q., Martinez, C. A., Arcipowski, K. M., Zhu, Y., Gutierrez-Diaz, B. T., Wang, K. K., Johnson, M. R., Volk, A. G., Wang, F., Wu, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1740 · Cited by 99
Rodell, C. B., Ahmed, M. S., Garris, C., Pittet, M. J., & Weissleder, R. (2019) · Theranostics · doi:10.7150/thno.35434 · Cited by 99
Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide
Xia, X., Huang, C., Liao, Y., Liu, Y., He, J., Guo, Z., Jiang, L., Wang, X., Liu, J., & Huang, H. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1227-7 · Cited by 97
Dai, X., Meng, J., Deng, S., Zhang, L., Wan, C., Lu, L., Huang, J., Hu, Y., Zhang, Z., Li, Y., et al. (2020) · Theranostics · doi:10.7150/thno.42385 · Cited by 86
Self-citationLi, Y., Chen, S., Chi, Y., Yang, Y., Chen, X., Wang, H., Lv, Z., Wang, J., Yuan, L., Huang, P., et al. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0182-0 · Cited by 74
Mattern, M. R., Wu, J., & Nicholson, B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.005 · Cited by 67
Guo, F., Zhang, C., Wang, F., Zhang, W. J., Shi, X., Zhu, Y., Fang, Z., Yang, B., & Sun, Y. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0473-8 · Cited by 66
Self-citationToward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics
Lill, J. R., & Wertz, I. E. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.01.005 · Cited by 52
Li, L., Wei, J., Li, S., Jacko, A. M., Weathington, N. M., Mallampalli, R. K., Zhao, J., & Zhao, Y. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.06.011 · Cited by 51
Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?
López‐Castejón, G., & Edelmann, M. J. (2016) · Mediators of Inflammation · doi:10.1155/2016/3481371 · Cited by 49
Perkins, H., Khodai, T., Mechiche, H., Colman, P., Burden, F., Laxton, C. D., Horscroft, N., Corey, T., Rodrigues, D., Rawal, J. K., et al. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9687-y · Cited by 27
Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies
Gutierrez-Diaz, B. T., Gu, W. J., & Ntziachristos, P. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.02.004 · Cited by 26
Lai, C.-Y., Yeh, D., Lu, C.-H., Liu, Y., Chuang, Y.-C., Ruan, J., Kao, C., Huang, L.-R., & Chuang, T. (2020) · Cancers · doi:10.3390/cancers12010148 · Cited by 25
Rubio‐Infante, N., Ilhuicatzi-Alvarado, D., Torres‐Martínez, M., Reyes‐Grajeda, J. P., Nava‐Acosta, R., González‐González, E., & Moreno‐Fierros, L. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26216 · Cited by 22
Cited by
The cancer metabolic reprogramming and immune response
Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01316-8 · Cited by 1,312
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
Pu, Y., & Ji, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.874589 · Cited by 297
The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity
Chen, Y., Gao, J., Ma, M., Wang, K., Liu, F., Yang, F., Zou, X., Cheng, Z., & Wu, D. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2344905 · Cited by 13
Metadata
- Authors
- Dai, X., Lu, L., Deng, S., Meng, J., Wan, C., Huang, J., Sun, Y., Hu, Y., Wu, B., Wu, G., Lovell, J. F., Jin, H., & Yang, K.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2020
- Volume
- 10
- Issue
- 20
- Pages
- 9332-9347
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3044603290
- Cited by
- 288
- References
- 53
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.